BLISS GVS PHARMA LTD. - Announcement under Regulation 30 (LODR)-Credit Rating

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No. SEBI/HO/CFD/CSD-PoD-1/P/CIR/2023/123 dated July 13, 2023, we would like to inform you that, CRISIL Ratings Limited vide its press releases dated June 19, 2024 bearing ref. no. RL/GDS2784/346423/BLR/0624/91401, has reaffirmed/assigned the ratings outstanding for the debt instruments/facilities of the Company, and the rating actions by CRISIL Ratings on the ratings as on date. Enclosed herewith intimation on the same.